Latest Strategic Partnerships News

Patriot Battery Metals reported a Q3 net loss of $2.23 million and a nine-month loss of $5.60 million, reflecting heavy investment in its flagship Shaakichiuwaanaan lithium project. A strategic $69 million private placement with Volkswagen post-quarter end underscores growing industry confidence.

Scorpion Minerals Limited has had its trading suspension lifted following an announcement about a potential joint venture and capital raising, signaling renewed market activity.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Mirvac's 1H25 results reveal a modest decline in EBIT and operating profit, yet the company signals strong growth prospects fueled by residential sales momentum, sustainable development, and strategic capital partnering.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.

BPM Minerals has commenced a significant 6,000m aircore drilling program at its Claw Gold Project in Western Australia, aiming to extend known gold mineralisation along an 8km corridor adjacent to Capricorn Metals' Mount Gibson Gold Project.

Prophecy International Holdings has posted a record half-year revenue of $11.6 million for H1 FY25, driven by strong demand for its AI-enabled cybersecurity and data integration products. The company’s transition to subscription models and expansion into new global markets underpin a positive outlook.

Recce Pharmaceuticals has temporarily paused trading of its securities, signaling a potentially significant development pending further disclosure.

Neurotech International has inked a development deal with RH Farma to produce a pharmaceutical-grade cannabinoid drug targeting pediatric neurodevelopmental disorders, leveraging advanced European extraction technology.

Carnaby Resources has reported robust drill results from its Greater Duchess copper-gold project in Queensland, reinforcing the project's significant resource growth potential as pre-feasibility studies advance.